Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.1K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.0K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.0K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adult sex ratios in captive reptiles, birds and mammals vary with the sex determination system.

Scientific reports·2026
Same author

Neighborhood environment and cognitive functioning in middle-aged and older population: A mediating role of physical activity.

International journal of hygiene and environmental health·2025
Same author

Dopamine D4 Receptor Agonist Drastically Increases Delta Activity in the Thalamic Nucleus Reuniens: Potential Role in Communication between Prefrontal Cortex and Hippocampus.

International journal of molecular sciences·2023
Same author

AGN as potential factories for eccentric black hole mergers.

Nature·2022
Same author

Hierarchical Black Hole Mergers in Active Galactic Nuclei.

Physical review letters·2019
Same author

Effects of p.o. administered xylitol in cats.

Journal of veterinary pharmacology and therapeutics·2018

Related Experiment Video

Updated: Mar 11, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

Zabofloxacin for chronic bronchitis.

B Kocsis1, D Szabo2

  • 1Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary. kocsis.bela@med.semmelweis-univ.hu.

Drugs of Today (Barcelona, Spain : 1998)
|November 25, 2016
PubMed
Summary
This summary is machine-generated.

Zabofloxacin, a new fluoroquinolone antibiotic, shows effectiveness comparable to moxifloxacin for treating lower respiratory tract infections. It is well-tolerated, offering a potential new option for chronic bronchitis antibacterial therapy.

Keywords:
DW-224aDW-224aaFluoroquinolonesRespiratory tract infectionZabofloxacin

More Related Videos

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

2.1K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.6K

Related Experiment Videos

Last Updated: Mar 11, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

2.1K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.6K

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Lower respiratory tract infections (LRTIs) present a significant clinical challenge.
  • Bacterial infections, particularly in chronic bronchitis, necessitate effective antibacterial treatment.
  • Fluoroquinolones are broad-spectrum antibiotics with good tissue penetration, commonly used for LRTIs.

Purpose of the Study:

  • To review the antibacterial efficacy, pharmacokinetics, and toxicity of zabofloxacin.
  • To discuss recent advances in fluoroquinolone use for chronic bronchitis.
  • To compare zabofloxacin with moxifloxacin in treating respiratory tract infections.

Main Methods:

  • Literature review and summary of preclinical and clinical data on zabofloxacin.
  • Comparative analysis of zabofloxacin and moxifloxacin efficacy against key respiratory pathogens.
  • Evaluation of safety and tolerability profiles for both agents.

Main Results:

  • Zabofloxacin demonstrated non-inferiority to moxifloxacin against common Gram-positive and Gram-negative respiratory pathogens.
  • The novel fluoroquinolone exhibited favorable pharmacokinetic properties and tissue penetration.
  • Zabofloxacin was well-tolerated in both oral and parenteral administration routes.

Conclusions:

  • Zabofloxacin is a promising antimicrobial agent for treating chronic bronchitis and other LRTIs.
  • Its efficacy and safety profile support its use as an alternative to existing fluoroquinolones.
  • Further research may solidify zabofloxacin's role in respiratory infection management.